Bellicum Pharmaceuticals, Inc. Gains 146.15%
Mon, May 08, 2023 at 08:17 PM
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) soared at $0.96, a gain of 146.2%. On Mon, May 08, 2023, BLCM:NASDAQ touched a New 2-Week High of $0.96. From Mon, Apr 24, 2023, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Mon, May 08, 2023 at $1.31 with a volume of 100M+.
About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.
Top 10 Gainers:
- Trevena, Inc. (TRVN:NASDAQ), 382.25%
- Ohmyhome Limited (OMH:NASDAQ), 328.71%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 146.15%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 77.78%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 75.6%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 59.74%
- MoneyLion Inc. Class A (ML:NYSE), 49.92%
- Immuron Limited (IMRN:NASDAQ), 43.32%
- VivoPower International PLC (VVPR:NASDAQ), 41.7%
- Lightning eMotors Inc (ZEV:NYSE), 39.47%